Monte Rosa Therapeutics Inc.
Organization details
- Legal name
- Monte Rosa Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- GLUE
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001826457
Board of directors
-
Alexander Mayweg · DirectorSince 2023
- Since 2023
-
Andrew N. Schiff · DirectorSince 2023
-
Anthony M. Manning · DirectorSince 2023
-
Chandra P. Leo · DirectorSince 2025
-
Christine Siu · DirectorSince 2023
-
Eric A. Hughes · DirectorSince 2024
-
Jan Skvarka · DirectorSince 2023
-
Kimberly Blackwell · DirectorSince 2023
-
Markus Warmuth · Director · President & CEOSince 2023
Chief executives
Director election results
Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
79.0%
-
99.0%
-
99.1%
Board connections
6 of this board's directors also sit on 10 other boards. 10 are in the same sector.
-
Black Diamond Therapeutics Inc. Same sectorvia Alexander Mayweg and Ali Behbahani
-
Zentalis Pharmaceuticals Inc. Same sectorvia Jan Skvarka and Kimberly Blackwell
-
Aclaris Therapeutics Inc. Same sectorvia Andrew N. Schiff
-
CRISPR Therapeutics AG Same sectorvia Ali Behbahani
-
CVRx Inc. Same sectorvia Ali Behbahani
-
Century Therapeutics Inc. Same sectorvia Kimberly Blackwell
-
Korro Bio Inc. Same sectorvia Ali Behbahani
-
Nkarta Inc. Same sectorvia Ali Behbahani
-
Palatin Technologies Inc. Same sectorvia Anthony M. Manning
-
SpyGlass Pharma Inc. Same sectorvia Ali Behbahani
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $4,111,335
- 37 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 5, 2026 | Bowen Matthew Officer (Principal Accounting Officer) | Open-market sale | −13 | $10.56 | $137 |
| Jul 16, 2026 | Markus Warmuth Director, Officer (President & CEO) | Open-market sale | −9,500 | $23.18 | $220,210 |
| Jul 15, 2026 | Champoux Jennifer Officer (Chief Operating Officer) | Option exercise | +4,351 | $3.98 | $17,317 |
| Jul 15, 2026 | Champoux Jennifer Officer (Chief Operating Officer) | Open-market sale | −4,351 | $23.38 | $101,726 |
| Jul 6, 2026 | Townson Sharon Officer (Chief Scientific Officer) | Option exercise | +6,000 | $6.14 | $36,840 |
| Jul 6, 2026 | Townson Sharon Officer (Chief Scientific Officer) | Open-market sale | −5,600 | $23.25 | $130,200 |
| Jul 6, 2026 | Townson Sharon Officer (Chief Scientific Officer) | Open-market sale | −400 | $24.13 | $9,652 |
| Jul 1, 2026 | Ali Behbahani Director | Other | −1,000,000 | — | — |
| Jul 1, 2026 | Ali Behbahani Director | Other | +15,000 | — | — |
| Jul 1, 2026 | Ali Behbahani Director | Other | −15,000 | — | — |
| Jun 30, 2026 | Janku Filip Officer (Chief Medical Officer) | Option exercise | +5,407 | $13.41 | $72,508 |
| Jun 30, 2026 | Janku Filip Officer (Chief Medical Officer) | Open-market sale | −5,407 | $24.50 | $132,472 |
| Jun 29, 2026 | Janku Filip Officer (Chief Medical Officer) | Option exercise | +6,000 | $7.56 | $45,360 |
| Jun 29, 2026 | Anthony M. Manning Director | Option exercise | +10,000 | $4.16 | $41,600 |
| Jun 29, 2026 | Janku Filip Officer (Chief Medical Officer) | Open-market sale | −6,000 | $22.95 | $137,700 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Monte Rosa Therapeutics Inc.
Who is the CEO of Monte Rosa Therapeutics Inc.?
Markus Warmuth is Monte Rosa Therapeutics Inc.'s President & CEO.
How many directors are on Monte Rosa Therapeutics Inc.'s board?
Monte Rosa Therapeutics Inc.'s board has 10 directors: Alexander Mayweg, Ali Behbahani, Andrew N. Schiff, Anthony M. Manning, Chandra P. Leo, Christine Siu, Eric A. Hughes, Jan Skvarka, Kimberly Blackwell and Markus Warmuth.
Are Monte Rosa Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Monte Rosa Therapeutics Inc. insiders made no open-market purchases and sold $4.1 million of shares in 37 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="monte-rosa-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.